Watershed Private Wealth LLC purchased a new position in Lemonade, Inc. (NYSE:LMND – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,790 shares of the company’s stock, valued at approximately $286,000.
Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Dimensional Fund Advisors LP raised its holdings in shares of Lemonade by 9.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 64,665 shares of the company’s stock valued at $1,067,000 after buying an additional 5,778 shares in the last quarter. Squarepoint Ops LLC raised its stake in shares of Lemonade by 436.2% during the second quarter. Squarepoint Ops LLC now owns 45,573 shares of the company’s stock worth $752,000 after acquiring an additional 37,073 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Lemonade by 388.7% in the 2nd quarter. Millennium Management LLC now owns 165,689 shares of the company’s stock worth $2,734,000 after acquiring an additional 131,784 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in shares of Lemonade by 9.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 29,194 shares of the company’s stock valued at $482,000 after purchasing an additional 2,582 shares in the last quarter. Finally, Algert Global LLC grew its holdings in shares of Lemonade by 6.8% during the 2nd quarter. Algert Global LLC now owns 82,883 shares of the company’s stock valued at $1,368,000 after purchasing an additional 5,295 shares during the last quarter. Hedge funds and other institutional investors own 80.30% of the company’s stock.
Insider Transactions at Lemonade
In related news, insider John Sheldon Peters sold 28,985 shares of Lemonade stock in a transaction that occurred on Monday, December 30th. The stock was sold at an average price of $38.67, for a total transaction of $1,120,849.95. Following the sale, the insider now directly owns 69,508 shares in the company, valued at $2,687,874.36. The trade was a 29.43 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Maria Angelidis-Smith acquired 18,512 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was purchased at an average price of $27.42 per share, with a total value of $507,599.04. Following the acquisition, the director now owns 18,512 shares of the company’s stock, valued at $507,599.04. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders sold 900,499 shares of company stock valued at $39,114,376. Company insiders own 12.50% of the company’s stock.
Lemonade Trading Up 5.0 %
Lemonade (NYSE:LMND – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported ($0.95) earnings per share for the quarter, beating the consensus estimate of ($1.02) by $0.07. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. The business had revenue of $136.60 million for the quarter, compared to analysts’ expectations of $129.10 million. During the same quarter in the previous year, the business posted ($0.88) earnings per share. The firm’s revenue for the quarter was up 19.3% compared to the same quarter last year. On average, sell-side analysts expect that Lemonade, Inc. will post -3.06 earnings per share for the current year.
Wall Street Analyst Weigh In
Several analysts have weighed in on LMND shares. JMP Securities boosted their price target on shares of Lemonade from $40.00 to $60.00 and gave the stock a “market outperform” rating in a research note on Friday, November 22nd. BMO Capital Markets boosted their target price on Lemonade from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Thursday, November 21st. Morgan Stanley raised Lemonade from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $23.00 to $42.00 in a research note on Wednesday, November 20th. Keefe, Bruyette & Woods lowered Lemonade from a “market perform” rating to an “underperform” rating and increased their price objective for the company from $18.00 to $21.00 in a research note on Thursday, November 7th. Finally, Piper Sandler lifted their target price on shares of Lemonade from $25.00 to $44.00 and gave the stock a “neutral” rating in a research note on Thursday, November 21st. Three analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $32.67.
View Our Latest Report on Lemonade
Lemonade Company Profile
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Featured Articles
- Five stocks we like better than Lemonade
- Insider Trades May Not Tell You What You Think
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Why Invest in 5G? How to Invest in 5G Stocks
- What Does the Future Hold for Eli Lilly?
- What is the Shanghai Stock Exchange Composite Index?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.